Latest AI and machine learning research in hematology for healthcare professionals.
Hemoglobin (Hb), a well-characterized protein central to oxygen transport and molecular medicine, serves as a model for studying how sequence variations influence protein structure and function. Its precise activity depends on tightly regulated structural dynamics, which can be disrupted by mutations that give rise to structural hemoglobinopathies—including sickle cell disease, unstable hemoglobin...
Circulating blood cell clusters (CCCs) containing red blood cells (RBCs), white blood cells (WBCs), and platelets are significant biomarkers linked to conditions like thrombosis, infection, and inflammation. Flow cytometry, paired with fluorescence staining, is commonly used to analyze these cell clusters, revealing cell morphology and protein profiles. While computational approaches based on mach...
Annotating single-cell and spatial RNA-seq data can be greatly enhanced by leveraging bulk RNA-seq, which remains a cost-effective and well-establishe...
Systemic chronic inflammation is a major determinant of aging and disease risk, yet current biomarkers such as the Inflammatory Age (iAge) clock and o...
Context-specific protein-protein interaction (PPI) drive heterogeneity of primary tumor, forming a formidable challenge to effective cancer therapy. H...
Single-cell chromatin accessibility offers unique insights into transcriptional regulation beyond gene expression. However, paired datasets of these t...
Humans are exposed to thousands of chemicals throughout their life. Many of these chemicals are detected in blood and have been catalogued in the Bloo...
Acute myeloid leukemia (AML) is a hematological cancer characterized by genetic diversity and poor clinical outcomes. Among various genetic mutations ...
Extracellular vesicles (EVs) mediate tumor-immune cell communication by carrying protein cargo that can immediately modulate signaling and antigen pre...
The bone marrow (BM) is the main site of haematopoiesis in adult life. Our understanding of the pathogenesis of BM-derived blood cancers is limited by...
Immunological aging (immunosenescence) drives increased susceptibility to infections and reduced vaccine efficacy in elderly populations. Current bulk...
Recent advances in high-throughput single-cell technologies have enabled characterization of cellular states across distinct omics layers, yielding co...
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease caused by the loss of motor neurons. Accurate and accessible blood-based diag...
Acute myeloid leukemia (AML) often enters remission after chemotherapy but frequently relapses due to chemotherapy-resistant leukemic stem cells (LSCs...
Disruption of the brain endothelial barrier is a hallmark of traumatic brain injury (TBI), and contributes to cerebral edema, coagulopathy, and delaye...
To deliver clinically relevant insights from large patient cohorts profiled with single-cell technologies, a key challenge is to relate sample-level a...
Early outcome prediction after acute traumatic spinal cord injury (SCI) is challenging due to pathological complexities and population heterogeneity. ...
Despite advances in central nervous system (CNS)-protective anesthetic and surgical strategies, perioperative stroke remains a significant concern in ...
Evaluation of bone marrow morphology by experienced hematologists is key in the diagnosis of myeloid neoplasms, especially to detect subtle signs of d...
Individuals homozygous for the Alpha-1 Antitrypsin (AAT) Z allele (Pi*ZZ) exhibit heterogeneity in COPD risk. COPD occurrence in non-smokers with AAT ...